共 125 条
[11]
Brusco L(2000)Elevated steroid sulfatase expression in breast cancers J Steroid Biochem Mol Biol 73 141-5
[12]
Fuqua SAW(2003)Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma Cancer Res 63 2762-70
[13]
Geisler J(2000)In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE Cancer Res 60 3394-6
[14]
Reed MJ(2006)In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy Clin Cancer Res 12 5543-9
[15]
Purohit A(2011)In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification Drug Metab Dispos 39 1235-46
[16]
Woo LWL(2012)In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes Drug Metab Dispos 40 1268-78
[17]
Newman SP(2013)A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer Breast Cancer Res Treat 140 73-82
[18]
Potter BVL(2004)Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats Br J Cancer 91 1399-404
[19]
Dowsett M(1993)The importance of modeling interoccasion variability in population pharmacokinetic analyses J Pharmacokinet Biopharm 21 735-50
[20]
Goss P(1994)Comparison of the Akaike information criterion, the Schwarz criterion and the F test as guides to model selection J Pharmacokinet Pharmacodyn 22 431-45